How effective is drug therapy in heterozygous familial hypercholesterolemia?
- 30 September 1993
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 72 (10) , D54-D58
- https://doi.org/10.1016/0002-9149(93)90011-z
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Drug therapy of hyperlipidemiaCurrent Problems in Cardiology, 1992
- Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group.BMJ, 1991
- Beneficial Effects of Colestipol-Niacin on Coronary AtherosclerosisPublished by American Medical Association (AMA) ,1990
- Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein BNew England Journal of Medicine, 1990
- Treatment of familial hypercholesterolaemia: a controlled trial of the effects of pravastatin or cholestyramine therapy on lipoprotein and apolipoprotein levelsJournal of Internal Medicine, 1990
- Regression of Tendon Xanthomas in Patients With Familial Hypercholesterolemia Treated With LovastatinSouthern Medical Journal, 1990
- Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsArchives of internal medicine (1960), 1988
- Lovastatin (Mevinolin) in the Treatment of Heterozygous Familial HypercholesterolemiaAnnals of Internal Medicine, 1987
- EFFECTS OF SYNVINOLIN (MK-733) ON PLASMA LIPIDS IN FAMILIAL HYPERCHOLESTEROLAEMIAThe Lancet, 1986
- Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.Journal of Clinical Investigation, 1984